Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2011

01-07-2011 | Clinical Practice: Clinical Images

Elephantiasis Nostras Verrucosa of the Pannus

Authors: Samuel Clark Berngard, BS, MSIV, MD candidate, Vignesh Narayanan, MD, Assistant Professor of Medicine

Published in: Journal of General Internal Medicine | Issue 7/2011

Login to get access

Excerpt

A 54-year-old man with morbid obesity and congestive heart failure presented with paroxysmal nocturnal dyspnea, bilateral lower extremity edema and weight gain. Physical exam revealed a large abdominal pannus with lichenified skin containing cobblestone-like verrucous nodules and papules with hyperpigmentation (Figs. 1 and 2) . The pannus completely encircled the patient’s genitals and left a fibrotic tract from which he urinated. The dermatological findings are consistent with elephantiasis nostras verrucosa—a dermatologic disorder secondary to chronic non-filarial lymphedema caused by bacterial or non-infectious lymphatic obstruction. Epidermal changes and fibrosis of the dermis and subcutaneous tissue are characteristic features13. Diagnosis is based on exam findings, but imaging and biopsy are used to exclude malignancy such as lymphoma and angiosarcoma5. Topical keratolytics, emollients, retinoids and surgical debridement are only minimally effective1 , 4. The patient was treated for decompensated heart failure and was discharged home with outpatient follow-up to be evaluated for an elective panniculectomy.
Literature
1.
go back to reference Sisto K, Khachemoune A. Elephantiasis nostras verrucosa: a review. Am J Clin Dermatol. 2008;9:141–146.PubMedCrossRef Sisto K, Khachemoune A. Elephantiasis nostras verrucosa: a review. Am J Clin Dermatol. 2008;9:141–146.PubMedCrossRef
2.
go back to reference Yoho RM, Budny AM, Pea AS. Elephantiasis nostras verrucosa. J Am Podiatr Med Assoc. 2006;96(5):442–444.PubMed Yoho RM, Budny AM, Pea AS. Elephantiasis nostras verrucosa. J Am Podiatr Med Assoc. 2006;96(5):442–444.PubMed
3.
go back to reference Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007;56(6):901–916.PubMedCrossRef Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007;56(6):901–916.PubMedCrossRef
4.
go back to reference Boyd J. Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene. J Drugs Dermatol. 2004;3(4):446–448.PubMed Boyd J. Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene. J Drugs Dermatol. 2004;3(4):446–448.PubMed
5.
go back to reference Vaccaro M, Borgia F, Guarneri F, et al. Elephantiasis nostras verrucosa. Int J Dermatol. 2000;39:764–766.PubMedCrossRef Vaccaro M, Borgia F, Guarneri F, et al. Elephantiasis nostras verrucosa. Int J Dermatol. 2000;39:764–766.PubMedCrossRef
Metadata
Title
Elephantiasis Nostras Verrucosa of the Pannus
Authors
Samuel Clark Berngard, BS, MSIV, MD candidate
Vignesh Narayanan, MD, Assistant Professor of Medicine
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2011
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-011-1653-5

Other articles of this Issue 7/2011

Journal of General Internal Medicine 7/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.